Definitive Healthcare (DH) EBITDA Margin (2020 - 2025)
Historic EBITDA Margin for Definitive Healthcare (DH) over the last 6 years, with Q3 2025 value amounting to 14.47%.
- Definitive Healthcare's EBITDA Margin rose 3449900.0% to 14.47% in Q3 2025 from the same period last year, while for Sep 2025 it was 122.67%, marking a year-over-year increase of 1201800.0%. This contributed to the annual value of 281.85% for FY2024, which is 1506700.0% down from last year.
- According to the latest figures from Q3 2025, Definitive Healthcare's EBITDA Margin is 14.47%, which was up 3449900.0% from 6.86% recorded in Q2 2025.
- Definitive Healthcare's 5-year EBITDA Margin high stood at 6.86% for Q2 2025, and its period low was 579.95% during Q2 2024.
- Over the past 5 years, Definitive Healthcare's median EBITDA Margin value was 20.73% (recorded in 2023), while the average stood at 111.04%.
- In the last 5 years, Definitive Healthcare's EBITDA Margin crashed by -5601400bps in 2024 and then soared by 5730800bps in 2025.
- Quarter analysis of 5 years shows Definitive Healthcare's EBITDA Margin stood at 28.28% in 2021, then surged by 39bps to 17.39% in 2022, then increased by 12bps to 15.29% in 2023, then plummeted by -946bps to 159.84% in 2024, then soared by 91bps to 14.47% in 2025.
- Its last three reported values are 14.47% in Q3 2025, 6.86% for Q2 2025, and 312.19% during Q1 2025.